02:17:59 EST Sun 17 Jan 2021
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for C:LBL from 2020-01-16 to 2021-01-15 - 27 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2021-01-05 23:10C:LBLLattice Biologics Ltd0.085News ReleaseLattice Biologics does not say why stock is up
2020-09-03 00:27C:LBLLattice Biologics Ltd0.035News ReleaseLattice ceases AmnioBoost trials over lack of patients
2020-08-31 20:05C:LBLLattice Biologics Ltd0.04News ReleaseLattice Biologics loses $319,739 (U.S.) in Q3 FY 2020
2020-08-31 17:14C:LBLLattice Biologics Ltd0.04SEDAR MD & ASEDAR MD & A
2020-08-31 17:07C:LBLLattice Biologics Ltd0.04SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2020-08-18 10:59C:LBLLattice Biologics Ltd0.05News ReleaseLattice issues 18 M shares to settle litigation
2020-07-22 18:47C:LBLLattice Biologics Ltd0.05Shares for DebtLattice Biologics 18 million shares for debt
2020-06-22 12:36C:LBLLattice Biologics Ltd0.05SEDAR Early Warning ReportSEDAR Early Warning Report
2020-06-08 19:36C:LBLLattice Biologics Ltd0.05News ReleaseLattice Biologics issues 16.76 million shares for debt
2020-06-02 13:25C:LBLLattice Biologics Ltd0.055News ReleaseLattice loses $853,717 in fiscal Q2 2020
2020-06-01 19:40C:LBLLattice Biologics Ltd0.055SEDAR MD & ASEDAR MD & A
2020-06-01 19:30C:LBLLattice Biologics Ltd0.055SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2020-05-28 17:25C:LBLLattice Biologics Ltd0.055Shares for DebtLattice Biologics 16.76 million shares for debt
2020-05-11 12:52C:LBLLattice Biologics LtdNews ReleaseLattice appoints Green to clinical development division
2020-04-15 12:52C:LBLLattice Biologics Ltd0.095News ReleaseLattice reprices options to buy three million shares
2020-04-07 02:11C:LBLLattice Biologics Ltd0.12News ReleaseLattice enters definitive deal for $6M at-will facility
2020-03-17 08:23C:LBLLattice Biologics Ltd0.09News ReleaseLattice begins enrolling patients for AmnioBoost trial
2020-03-13 07:15C:LBLLattice Biologics Ltd0.075News ReleaseLattice to evaluate AmnioBoost for coronavirus patients
2020-03-11 18:04C:LBLLattice Biologics Ltd0.025News ReleaseLattice Biologics plans $726,200 (U.S.) debt conversion
2020-03-03 17:06C:LBLLattice Biologics Ltd0.02News ReleaseLattice's TSX-V listing transferred to Tier 2
2020-03-03 16:46C:LBLLattice Biologics Ltd0.02MiscellaneousLattice Biologics moves to Tier 2
2020-02-28 09:31C:LBLLattice Biologics Ltd0.02News ReleaseLattice Biologics loses $69,893 (U.S.) in Q1 2020
2020-02-28 07:06C:LBLLattice Biologics Ltd0.02SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2020-02-28 07:06C:LBLLattice Biologics Ltd0.02SEDAR MD & ASEDAR MD & A
2020-01-29 02:22C:LBLLattice Biologics Ltd0.025News ReleaseLattice loses $1-million (U.S.) in fiscal 2019
2020-01-28 22:35C:LBLLattice Biologics Ltd0.025SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2020-01-28 22:35C:LBLLattice Biologics Ltd0.025SEDAR MD & ASEDAR MD & A